P050 CARDIOVASCULAR RISK OF BURTON’S TYROSINE KINASE INHIBITORS: AN UPDATED SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

IF 5.7 2区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

Canadian Journal of Cardiology Pub Date : 2026-10-01 DOI:10.1016/j.cjca.2026.07.060

H. Bhatt, I. Alqassas, F. Foroutan, R. Lu, M. Dryburgh, N. Butani, J.G. Lee, A. Orchanian-Cheff, D.P. Leong, A. Prica, D. Addison, L. Mozessohn, M. Fradley, A. Vijenthira, P. Chakraborty, K. Nanthakumar, P. Thavendiranathan, H. Abdel-Qadir

引用次数: 0

查看原文本刊更多论文

伯顿氏酪氨酸激酶抑制剂的心血管风险P050：一项最新的系统综述和网络荟萃分析

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Canadian Journal of Cardiology 医学-心血管系统

CiteScore

9.20

自引率

8.10%

发文量

546

审稿时长

32 days

期刊介绍： The Canadian Journal of Cardiology (CJC) is the official journal of the Canadian Cardiovascular Society (CCS). The CJC is a vehicle for the international dissemination of new knowledge in cardiology and cardiovascular science, particularly serving as the major venue for Canadian cardiovascular medicine.